October 13-14 | Munich
Proveris is a silver sponsor of the Respiratory Drugs Hybrid Summit: from Development to Delivery, which will be held in- person from October 13-14 and as a virtual conference.
An in-person presentation will be given by Maria Smith, Application and Business Development Director for Proveris Laboratories. The presentation will discuss the quantification of pulmonary drug deposition and will introduce a novel in vitro tool for increasing the efficiency of inhaled drug product development.
This Respiratory Drugs Hybrid Summit: from Development to Delivery is a cutting-edge conference that will focus on the latest developments and trends in the Pharma industry. Expert speakers will address a wide range of topics, such as: novel technologies for pulmonary & nasal delivery, innovative development of inhalation devices, dry-powder inhalers (DPIs) and metered-dose inhalers (MDIs), model validation, Pharma 4.0, digitalization, smart and digital inhalers, and sustainable manufacturing.
Learn more and register HERE.